Screening and treatment of Chlamydia trachomatis infections

BMJ (Online)

Volumn 340, Issue 7752, 2010, Pages 912-917

  Kalwij, Sebastian ^a,b   Macintosh, Mary ^b   Baraitser, Paula ^b  

^a Waldron Teaching Practice   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; OFLOXACIN;

CHLAMYDIASIS; DISEASE COURSE; HUMAN; INFECTION CONTROL; LABORATORY DIAGNOSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCREENING; SELF EVALUATION; SEXUAL BEHAVIOR; SINGLE DRUG DOSE; VAGINA SMEAR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTI-BACTERIAL AGENTS; CHLAMYDIA INFECTIONS; COMMUNITY PHARMACY SERVICES; CONTACT TRACING; FAMILY PRACTICE; FEMALE; HUMANS; MALE; MASS SCREENING; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; WORLD HEALTH; YOUNG ADULT;

EID: 77951556678     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c1915     Document Type: Review

References (30)

1. European Centre for Disease Prevention and Control. Chlamydia control in Europe. 2009.www.ecdc.europa.eu/en/publications/Publications/0906-GUI-Chlamydia- Control-in-Europe.pdf.
2. Centers for Disease Control and Prevention. Chlamydia screening factsheet. www.cdc.gov/std/Chlamydia/STDFact-Chlamydia.htm.
3. Molano M, Meijer CJ, Weiderpass E, Arslan A, Posso H, Franceschi S, et al. The natural course of Chlamydia trachomatis infection in asymptomatic Columbian women: a 5-year follow up. J Infect Dis 2005;191:907-16.
4. Adams EJ, Charlett A, Edmunds WJ, Hughes G. Chlamydia trachomatis in the United Kingdom: a systematic review and analysis of prevalence studies. Sex Transm Infect 2004;80:354-62.
5. Risser WL, Risser JMH. The incidence of pelvic inflammatory disease in untreated women infected with Chlamydia trachomatis: a structured review. Int J STD AIDS 2007;18:727-31.
6. Land JA, Van Bergen JEAM, Morre SA, Postma MJ. Epidemiology of Chlamydia trachomatis infection and the cost effectiveness of screening. Hum Reprod Update 2010;16:189-204.
7. Andersen B, Østergaard L, Puho E, Skriver MV, Schønheyder HC. Ectopic pregnancies and reproductive capacity after Chlamydia trachomatis positive and negative test results: a historical follow-up study. Sex Transm Dis 2005;32:377-381
8. Low N, Egger M, Sterne JA, Harbord RM, Ibrahim F, Lindblom B, et al. Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women's Cohort Study. Sex Transm Infect 2006;82:212-218
9. Bakken IJ, Skjeldestad FE, Lydersen S, Nordbø SA. Births and ectopic pregnancies in a large cohort of women tested for Chlamydia trachomatis. Sex Transm Dis 2007;34:739-743
10. Van Valkengoed IG, Morré SA, van den Brule AJ, Meijer CJ, Bouter LM, Boeke AJ. Overestimation of complication rates of Chlamydia trachomatis screening programmes - implications of cost-effectiveness analyses. Int J Epidemiol 2004;33:416-425
11. National Institute for Health and Clinical Excellence. Antenatal care: routine care for the healthy pregnant woman. CG62. 2008. www.nice.org.uk/ Guidance/CG62.
12. Adam EJ, Turner KM, Edmunds WJ. The cost effectiveness of opportunistic chlamydia screening in England. Sex Transm Infect 2007;83:267-275
13. Ostergaard L, Andersen B, Moller JK, Olesen. Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women; a cluster-randomized 1-year follow-up study. Clin Infect Dis 2000;31:951-957
14. Scholes D, Stergachis A, Heindrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996;334:1362-1366
15. Low N, Bender N, Nartey L, Redmond S, Shang A, Stepheson J. Rapid review of evidence for the effectiveness of screening for genital chlamydial infection in sexually active young women and men. National Institute for Health and Clinical Excellence, 2006.
16. Oakeshott P, Kerry S, Aghaizu A, Atherton H, Hay S, Taylor-Robinson D, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ 2010;340:c1642.
17. Low N, the SCREen project team. Publication report on chlamydia control activities in Europe. Euro Surveill 2008;13:28.
18. Satterwhite CL, Tian LH, Braxton J, Weinstock H. Chlamydia prevalence among women and men entering the national job training program: United States, 2003-2007. Sex Transm Dis 2010;37:63-67
19. Gift TL, Gaydos CA, Kent CK, Marazzo KM, Reitmeijer CA, Schillinger JA, et al. The program cost and cost- effectiveness of screening men for chlamydia to prevent pelvic inflammatory disease in women. Sex Transm Dis 2008;35:S66-75.
20. Marrazzo JM, Scholes D. Acceptability of urine-based screening for Chlamydia trachomatis to asymptomatic young men and their providers. Sex Transm Dis 2007;34:147-153
21. Watson EJ, Templeton A, Russell I, Paavonen J, Mardh PA, Stary A, et al. The accuracy and efficiency of screening tests for Chlamydia trachomatis: a systematic review. J Med Microbiol 2002;51:1021-1031
22. Tobin JM, Harinda V, Mani R. Which treatment for genital tract Chlamydia trachomatis infection? Int J STD AIDS 2004;15:737-739
23. Lamontagne S, Baster K, Emmett L, Nichols T, Randall S, McLean L, et al. Incidence and reinfection rates of genital chlamydial infection among women aged 16-24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group. Sex Transm Infect 2007;83:292-303.
24. Trelle S, Shang A, Nartey L, Cassell JA, Low N. Improved effectiveness of partner notification for patients with sexually transmitted infections: systematic review. BMJ 2007;334:354.
25. Low N, Welch J, Radcliffe K. Developing national outcome standards for the management of gonorrhoea and genital chlamydia in genitourinary medicine clinics. Sex Transm Infect 2004;80:223-229
26. Apoola A, Radcliffe KW, Das S, Robshaw V, Gilleran G, Kumari BS, et al. Patient preferences for partner notification. Sex Transm Infect 2006;82:327-329
27. Van Bergen JE, Spaargaren J, Götz HM, Vedhuijzen IK, Bindels PJ, Coenen TJ, et al. Population prevalence of Chlamydia trachomatis and Neisseria gonorrhoea in the Netherlands. Should asymptomatic persons be tested during population-based Chlamydia screening also for gonorrhoea or only if chlamydial infection is found? BMC Infect Dis 2006;6:42.
28. Pavlin NL, Parker R, Fairley CK, Gunn JM, Hocking J. Take the sex out of STI screening! Views of young women on implementing chlamydia screening in general practice. BMC Infect Dis 2008;8:62.
29. Heritage J, Jones M. A study of young peoples' attitudes to opportunistic Chlamydia testing in UK general practice. Reprod Health 2008;5:11.
30. Owens SL, Arora N, Quinn N. Utilising the internet to test for sexually transmitted infections: results of a survey and accuracy testing. Sex Transm Infect 2010;86:112-116